Diabetes Mellitus Clinical Trial
Official title:
Doctors and Web-based Self-management Support Pilot Study.
Doctors and web-based self-management support pilot study will test whether health professionals' observation of an online patient workshop on self-management of diabetes and participation in structured learning sessions on self-management strategies will change the attitudes and confidence of physicians and other health professionals regarding their willingness and ability to perform self-management interventions with patients. If this pilot suggests that attitudes and confidence levels can change, we hope to launch a larger study to examine this method of learning and its effectiveness in more detail.
The standard of care is that health professionals receive their usual education on
self-management, which ranges from minimal to modest, depending on the training site. They
will be identified and invited to attend by the program director and/or clinic managers.
Health professional participants will attend 60-90 minutes teaching sessions with other
health professionals, either in person or via Web-Ex, once per week for a total of 4 weeks.
The program director and/or clinic managers overseeing these health professionals will make
room for these sessions in their clinic schedule, so that you have no clinical or other
responsibilities during those times.
During the first session, the Principal Investigator will first read the informed
consent/fact sheet to the health professionals and ask for any questions. A copy of the
informed consent/fact sheet will be given to each health professional participant, and they
will be asked to provide their contact information on a sign up sheet. At that point, they
will complete their first survey questionnaire.
Between these group sessions, at the convenience of the participant, the health professional
will log-on to the online workshop to observe the patients' progress in the online course.
The health professional will be expected to log on 3 times per week for approximately 10
minutes at a time. The health professional will have 2 'homework' assignments during the
entire 4 weeks of learning sessions. These consist of thinking critically about how the
self-management techniques they observe patients using online might apply to other patients
the health professionals observe, whether online or in their clinics.
The health professionals will also be asked to complete voluntary pre- and post-course
surveys. There will be time set aside during the first and last learning sessions for them
to complete the surveys.
The final learning session will primarily be devoted to a focus group discussion of the
learning sessions. The total time commitment to the observational learning sessions is to
attend the 4 learning sessions (60-90 minutes apiece once per week), visit the patient
online workshop site 3 times per week (for at least 10 minutes a time), and do the
'homework' assignments (which are expected to take 10-20 minutes apiece to complete).
The health professionals will not actually participate in the online workshop for patients.
In fact, if they decide to participate in this project, they are instructed not interact in
any way with the patients in the online workshop. The health professionals must agree to
observe only, not to post on the discussion boards, and not to answer any messages that they
may receive via the online messaging system. The workshops are monitored by Stanford staff,
and they will take any action necessary if the health professionals alert them to the need
to respond to a patient.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |